echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Reduce the price by 90% and millions of people benefit! Collection crown pulse bracket 18 provinces and cities landed

    Reduce the price by 90% and millions of people benefit! Collection crown pulse bracket 18 provinces and cities landed

    • Last Update: 2021-01-19
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    On January 1st, the results of the national organization's centralized belt procurement were officially implemented in 18 provinces and cities, including Beijing, Tianjin, Shandong and Liaoning, where patients used the crown stent after harvesting.
    Nationan Health Insurance Bureau: From now on, the collection of crown vein bracket in 18 provinces and cities to implement 1 day, the national organization of the crown vein bracket centralized procurement of the first batch of 18 provinces and cities (regions), including Beijing, Tianjin, Hebei, Liaoning, Jilin, Heilongjiang, Jiangsu, Zhejiang, Fujian, Shandong, Hunan, Guangdong, Hainan, Guizhou, Yunnan, Gansu, Qinghai, Xinjiang (including the corps).
    the first batch of 18 provinces and cities (districts) to land in the local inventory of products reached an average of 33% of the agreed procurement, to meet the first month of medical institutions to meet the demand.
    the rest of the provinces will be implemented in January 2021, in an effort to get patients to use the crown stent after harvesting at an early time.
    Zhaohui, Director of the Pharmaceutical Price and Tender procurement Department of the State Health Insurance Administration: For patients, the first is a decline in the medical burden, a chrome stent, an average price reduction of 12,000 yuan.
    if an operation is performed with 1.5 stents, the individual burden of an insured person can be estimated to save 7000-8000 yuan.
    we are collecting chromium stents this time, more in line with the development of clinical use.
    we wanted to have a centralized band purchase, the price came down and the coronary stent was affordable for emergency patients.
    for non-emergency surgery, the abuse caused by the original possible over-marketing will also be reduced.
    how many ordinary people will benefit from the more than 1 million patients who benefit from the national collection coronary stent? How much will you save? State organization crown bracket centralized belt procurement in early November 2020 produced the results of the election, 10 selected varieties, from the average price of 13,000 yuan to about 700 yuan, a decline of more than 90%, is expected to save 11.7 billion yuan.
    the results of the election, various departments around the country carried out various preparations for the implementation of the landing.
    health insurance department urged the selected enterprises to sell according to the winning price, medical institutions according to the winning price procurement and use, while the introduction of health insurance payment policy, to ensure that the price reduction of the crown stent can make patients use, reimbursable.
    about 1 million coronary heart disease patients are implanted with heart stents every year, and patients can use the selected heart stents, which will greatly reduce the burden of medical treatment.
    Jinfu, deputy director of the National Health Insurance Administration: There are also concerns that after the price is lowered, enterprises are not stealing materials, in this regard we have a complete system design.
    The first enterprise is the first responsible person for quality, the second is quality assurance on the threshold of entry, the third is to participate in the recruitment process to have quality commitment, and the fourth government has quality supervision.
    most important one, I think the enterprise from the quality development, brand maintenance, it will take quality as a life.
    Chaohui, Director of the Medical Price and Tender procurement Department of the State Health Insurance Administration: The next step is to summarize the existing experience and further optimize the procurement rules.
    Because it is still in the exploration stage, so we mainly consider the clinical use of a relatively wide range of procurement amount is relatively large, more mature technical market competition is more adequate products, priority into the scope of collection.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.